Human Papillomavirus (HPV) News and Research

Latest Human Papillomavirus (HPV) News and Research

Two Staffordshire hospitals introduce pioneering technology to improve cervical cancer diagnosis

Two hospitals in Staffordshire have introduced a pioneering new technology designed to improve the speed and accuracy in diagnosing pre-cancerous conditions of the cervix.

From Zilico 5 Oct 2016

HPV vaccine can decrease incidence of cervical pre-cancers among young women, research shows

Every 20 minutes, someone in the United States receives a cancer diagnosis related to human papillomavirus. HPV causes cancer of the cervix, anus and throat.

29 Sep 2016

Specific HPV strain linked to better overall survival for oropharyngeal cancer patients

When it comes to cancer-causing viruses like human papillomavirus, or HPV, researchers are continuing to find that infection with one strain may be better than another.

28 Sep 2016

Study finds nonwhite transplant recipients at risk for skin cancer

A new study from Drexel University College of Medicine suggests all organ transplant recipients, regardless of race, should receive routine, total-body screenings for skin cancer.

21 Sep 2016

Researchers develop novel label-free method for detecting real-time DNA amplification

Research team led by Nagoya University develop a label-free method for detecting DNA amplification in real time based on refractive index changes in diffracted light.

7 Sep 2016

Many parents support HPV vaccine school-entry requirements with opt-out provisions

Requiring students to get vaccinated against the human papillomavirus, or HPV, to enter school could prevent many cancers linked to the virus, but University of North Carolina at Chapel Hill researchers found that many parents only support such requirements with opt-out provisions that could make the laws less effective.

19 Aug 2016

Fruit fly models may help scientists understand underlying mechanism of HPV-induced cancer

Human papillomavirus (HPV) is one of the most common sexually transmitted infections in the United States and has been identified as a primary cause of cervical cancer in women.

19 Aug 2016

Advances in head and neck cancer treatments: an interview with Prof. Argiris

Patients with head and neck cancer usually present with locally advanced disease and often require more than one type of treatment, which may include surgery, radiotherapy, and chemotherapy.

3 Aug 2016

Roche Diagnostics responds to HPV announcement

Roche Diagnostics welcomes the announcement by Public Health Minister, Jane Ellison, to introduce Human Papillomavirus (HPV) primary screening in England.

6 Jul 2016

TSRI scientists develop new strategy to design potential HIV vaccine candidates

Want to catch a criminal? Show a mugshot on the news. Want to stop HIV infections? Get the immune system to recognize and attack the virus's tell-tale structure. That's part of the basic approach behind efforts at The Scripps Research Institute to design an AIDS vaccine.

29 Jun 2016

Study shows women with CIN3 more likely to develop anogenital cancers

Women with a history of severe cervical intraepithelial neoplasia, a precancerous condition of the cervix that arises from infection with the human papillomavirus (HPV), had a long-term increased risk of developing anal, vulvar, and vaginal cancer.

29 Jun 2016

Drinking piping hot beverages may increase risk of esophagus tumors

Drinking piping hot coffee, tea and the caffeine-infused beverage yerba mate probably causes cancer, the World Health Organization announced Wednesday.

16 Jun 2016

Pembrolizumab drug shows significant clinical responses in metastatic head and neck cancer patients

Treating head and neck cancer patients with recurrent or metastatic disease with the PD-1 inhibitor pembrolizumab resulted in significant clinical responses in a fifth of the patients from a phase II clinical trial, researchers at the Abramson Cancer Center of the University of Pennsylvania and other institutions reported at the 2016 American Society of Clinical Oncology annual meeting.

7 Jun 2016

Loyola researchers detect tumor gene that may help predict survival outcomes in mouth cancer patients

Loyola researchers have identified a tumor gene that may help to predict survival outcomes in patients with cancer of the mouth and tongue.

5 May 2016

Combination of two diagnostic tests can decrease chance of missing tumors by sevenfold

Cytopathology researchers at Houston Methodist Hospital recently found that combining two diagnostic tests, Pap and high-risk human papillomavirus (hrHPV), dramatically decreased the chance of missing tumors and high-grade lesions by sevenfold.

4 May 2016

Self-collected vaginal swabs may help identify HPV infection

High risk, potentially cancer causing human papillomavirus infections are common among women in Papua New Guinea. But self sampling with vaginal swabs may provide materials that screen as accurately as the more labor-intensive approach using cervical samples obtained by clinicians.

30 Apr 2016

WHO outlines steps to close immunization gap across countries during World Immunization Week 2016

During World Immunization Week 2016, held 24-30 April, the World Health Organization highlights recent gains in immunization coverage, and outlines further steps countries can take to “Close the Immunization Gap” and meet global vaccination targets by 2020.

21 Apr 2016

Nivolumab drug shows survival benefit in phase III trial of patients with head and neck cancer

The immunotherapy drug nivolumab has become the first to show a survival benefit in head and neck cancer, after a major international trial found that it was more effective than standard chemotherapy.

20 Apr 2016

First-ever nivolumab drug trial for rare, malignant SCCA shows positive results

A rare malignancy known as squamous cell carcinoma of the anal canal (SCCA) is on the increase, and now researchers have reported results of the first-ever phase II clinical trial results for treatment with the immunotherapy drug nivolumab.

18 Apr 2016

HPV vaccination may be beneficial for CKD patients but not for kidney transplant recipients

Human papillomavirus (HPV) vaccination stimulates robust and sustained immune responses in girls and young women with chronic kidney disease (CKD) and those on dialysis, but less optimal responses to the vaccine were observed among those with a kidney transplant.

11 Apr 2016

Human Papillomavirus (HPV) News and Research

Latest Human Papillomavirus (HPV) News and Research

Two Staffordshire hospitals introduce pioneering technology to improve cervical cancer diagnosis

HPV vaccine can decrease incidence of cervical pre-cancers among young women, research shows

Specific HPV strain linked to better overall survival for oropharyngeal cancer patients

Study finds nonwhite transplant recipients at risk for skin cancer

Researchers develop novel label-free method for detecting real-time DNA amplification

Many parents support HPV vaccine school-entry requirements with opt-out provisions

Fruit fly models may help scientists understand underlying mechanism of HPV-induced cancer

Advances in head and neck cancer treatments: an interview with Prof. Argiris

Roche Diagnostics responds to HPV announcement

TSRI scientists develop new strategy to design potential HIV vaccine candidates

Study shows women with CIN3 more likely to develop anogenital cancers

Drinking piping hot beverages may increase risk of esophagus tumors

Pembrolizumab drug shows significant clinical responses in metastatic head and neck cancer patients

Loyola researchers detect tumor gene that may help predict survival outcomes in mouth cancer patients

Combination of two diagnostic tests can decrease chance of missing tumors by sevenfold

Self-collected vaginal swabs may help identify HPV infection

WHO outlines steps to close immunization gap across countries during World Immunization Week 2016

Nivolumab drug shows survival benefit in phase III trial of patients with head and neck cancer

First-ever nivolumab drug trial for rare, malignant SCCA shows positive results

HPV vaccination may be beneficial for CKD patients but not for kidney transplant recipients

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Human Papillomavirus (HPV) News and Research

Latest Human Papillomavirus (HPV) News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in